[HTML][HTML] Transcriptomic and proteomic assessment of tocilizumab response in a randomized controlled trial of patients hospitalized with COVID-19
H Shivram, JA Hackney, CM Rosenberger, A Teterina… - Iscience, 2023 - cell.com
Summary High interleukin (IL)-6 levels are associated with greater COVID-19 severity. IL-6
receptor blockade by tocilizumab (anti-IL6R; Actemra) is used globally for the treatment of …
receptor blockade by tocilizumab (anti-IL6R; Actemra) is used globally for the treatment of …
[HTML][HTML] Tocilizumab
CV Preuss, F Anjum - StatPearls [Internet], 2024 - ncbi.nlm.nih.gov
Objectives: Identify patients suitable for tocilizumab therapy based on their clinical
presentation and disease characteristics. Implement appropriate protocols for administering …
presentation and disease characteristics. Implement appropriate protocols for administering …
The association between tocilizumab therapy and the development of thrombosis in critically ill patients with COVID-19: a multicenter, cohort study
The use of tocilizumab for the management of COVID-19 emerged since it modulates
inflammatory markers by blocking interleukin 6 receptors. Concerns regarding higher …
inflammatory markers by blocking interleukin 6 receptors. Concerns regarding higher …
Effect of tocilizumab on mortality in patients with SARS-CoV-2 pneumonia caused by Delta or omicron variants: a propensity-matched analysis in Nimes university …
P Laffont-Lozes, D Laureillard, P Loubet, R Stephan… - Antibiotics, 2023 - mdpi.com
We aimed to assess the factors associated with mortality in patients treated with tocilizumab
for a SARS-CoV-2 pneumonia due to the delta or omicron variants of concern (VOC) and …
for a SARS-CoV-2 pneumonia due to the delta or omicron variants of concern (VOC) and …
Artificial intelligence assessment of the potential of tocilizumab along with corticosteroids therapy for the management of COVID-19 evoked acute respiratory distress …
C Segú-Vergés, L Artigas, M Coma, RW Peck - Plos one, 2023 - journals.plos.org
Acute respiratory distress syndrome (ARDS), associated with high mortality rate, affects up to
67% of hospitalized COVID-19 patients. Early evidence indicated that the pathogenesis of …
67% of hospitalized COVID-19 patients. Early evidence indicated that the pathogenesis of …
Uncovering the information immunology journals transmitted for COVID-19: A bibliometric and visualization analysis
J Zhao, J Zhu, C Huang, X Zhu, Z Zhu, Q Wu… - Frontiers in …, 2022 - frontiersin.org
Background Since the global epidemic of the coronavirus disease 2019 (COVID-19), a large
number of immunological studies related to COVID-19 have been published in various …
number of immunological studies related to COVID-19 have been published in various …
[引用][C] Ohoud Aljuhani, Khalid Al Sulaiman 2, 3, 4, 17Ε, Ghazwa B. Korayem 5, Ali F. Altebainawi 6, Samiah Alsohimi 7, 8, Rahaf Alqahtani 2, Saeedah Alfaifi 9, Aisha …
R Vishwakarma - Scientific Reports, 2024